
|Videos|September 7, 2021
Transperineal biopsy device PrecisionPoint shows promise
Author(s)Urology Times staff
“Through these 2 small punctures, we can manipulate the device with the methodology to sample the entire prostate, both anterior apical and the posterior regions, where we find the vast majority of our cancers,” says Matthew A. Allaway, MD.
Advertisement
In this video, Matthew J. Allaway, MD, discusses the The PrecisionPoint Transperineal Access System, a new and efficient methodology for detecting prostate cancers in patients. Allaway is the founder and president of Perinealogic, urologist and managing partner at Urology Associates, Cumberland, Maryland.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












